- Home
- INSE vs PRQR Comparison
INSE vs PRQR Comparison
Compare INSE & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSE
- PRQR
- Stock Information
- Founded
- INSE N/A
- PRQR 2012
- Country
- INSE United States
- PRQR Netherlands
- Employees
- INSE 1700
- PRQR N/A
- Industry
- INSE Computer Software: Prepackaged Software
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- INSE Technology
- PRQR Health Care
- Exchange
- INSE Nasdaq
- PRQR Nasdaq
- Market Cap
- INSE 263.7M
- PRQR 309.5M
- IPO Year
- INSE N/A
- PRQR 2014
- Fundamental
- Price
- INSE $10.00
- PRQR $3.65
- Analyst Decision
- INSE Buy
- PRQR Strong Buy
- Analyst Count
- INSE 3
- PRQR 4
- Target Price
- INSE $15.00
- PRQR $7.13
- AVG Volume (30 Days)
- INSE 89.7K
- PRQR 668.4K
- Earning Date
- INSE 11-07-2024
- PRQR 11-07-2024
- Dividend Yield
- INSE N/A
- PRQR N/A
- EPS Growth
- INSE N/A
- PRQR N/A
- EPS
- INSE N/A
- PRQR N/A
- Revenue
- INSE $297,900,000.00
- PRQR $20,506,357.00
- Revenue This Year
- INSE N/A
- PRQR $298.83
- Revenue Next Year
- INSE $3.93
- PRQR N/A
- P/E Ratio
- INSE N/A
- PRQR N/A
- Revenue Growth
- INSE N/A
- PRQR 306.68
- 52 Week Low
- INSE $7.51
- PRQR $1.18
- 52 Week High
- INSE $11.00
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- INSE 52.65
- PRQR 54.32
- Support Level
- INSE $9.89
- PRQR $3.57
- Resistance Level
- INSE $10.34
- PRQR $4.21
- Average True Range (ATR)
- INSE 0.39
- PRQR 0.24
- MACD
- INSE -0.03
- PRQR -0.08
- Stochastic Oscillator
- INSE 23.98
- PRQR 20.00
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments namely Gaming; Virtual Sports; Interactive and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.